Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Receivables - Other: 2011-2021

Historic Receivables - Other for Aytu Biopharma (AYTU) over the last 1 years, with Sep 2021 value amounting to $9,000.

  • Aytu Biopharma's Receivables - Other was N/A to $9,000 in Q3 2021 from the same period last year, while for Sep 2021 it was $9,000, marking a year-over-year change of. This contributed to the annual value of $21,000 for FY2021, which is N/A change from last year.
  • As of Q3 2021, Aytu Biopharma's Receivables - Other stood at $9,000, which was down 57.14% from $21,000 recorded in Q2 2021.
  • In the past 5 years, Aytu Biopharma's Receivables - Other ranged from a high of $42,000 in Q1 2021 and a low of $9,000 during Q3 2021.
  • In the last 1 years, Aytu Biopharma's Receivables - Other had a median value of $21,000 in 2021 and averaged $24,000.